Carlyle, Viyash Life Sciences to launch pharma investment platformCA Hull Investments, an affiliated entity of Carlyle Asia Partners and Viyash, and the platform will primarily focus on investment in Activ...
16 Nov, 2021, 05.34 PM IST
FDA issues Warning Letter to Mylan Laboratories Limited's Telangana plantThe US drug regulator in a letter on September 1 told the drug-maker that the FDA investigators found lapses in the plant as there were no ...
03 Sep, 2020, 11.57 AM IST
India must manufacture more APIs locally, depend less on China: ExpertsIndia, the world’s third-largest drug producer by volumes, imports 70% of its APIs from China. For some APIs, especially antibiotics, depen...
18 Jun, 2020, 07.48 AM IST
Coronavirus: Niti CEO to find ways to reduce drug import dependence on ChinaThe list has been compiled by the drug regulatory authority and contains antibiotics like azithromycin, amoxicillin, ofloxacin, metronidazo...
20 Feb, 2020, 09.37 AM IST
Solara Active Pharma to conduct internal probe on Nizatidine API amid Mylan recall"We understand from Mylan NV's press release dated January 8, 2020, that Mylan Pharmaceuticals has initiated a voluntary recall of three lo...
09 Jan, 2020, 11.23 AM IST
Mylan to invest $1 billion in India on capex in 6 yearsCurrently Mylan has 21 facilities and 15,000 employees working in India.
29 Sep, 2019, 12.47 PM IST
Mylan gets approval to launch HIV drug in India, says it will be priced “lower” than othersAround 21 lakh people are estimated to be living with HIV in India but only 14 lakh are known cases, according to the health ministry.
08 Aug, 2017, 01.01 PM IST
Natco will out-license molecules to big pharma: Amit Rajan, Director, Celogen LifeAmit Rajan, Director, Celogen Life says that Micro Labs will quickly come out of the FDA and midcap space as they have a good R&D pipeline.
10 Jun, 2016, 03.19 PM IST
India makes all Mylan HIV drugs for developing world: Rajiv Malik, President, MylanWe were second to enter the US in the marketing of a generic version of AstraZeneca's heartburn drug Nexium, but we still managed to build ...
21 Apr, 2016, 10.59 AM IST
CCI gives green signal to Mylan-Unichem dealIt observed that the proposed acquisition by Mylan was with the intent to export products to be manufactured at the said facility.
11 Jun, 2013, 08.20 PM IST
- Mylan Laboratories looks for partners to launch drugs
Matrix Laboratories, which was acquired by Mylan , is exploring new partnerships in India to launch about 100 products.
17 Aug, 2011, 06.02 PM IST
- Natco Pharma soars on drug licensing deal
Natco Pharma rose as much as 19 per cent after it struck a licensing and supply deal with US-based Mylan for its generic version of multipl...
11 Jun, 2008, 11.45 AM IST
- Matrix weighs Docpharma sale
Hyderabad-based Matrix Labs, in which US-based Mylan Labs holds a controlling stake, is toning up its business focus.
29 Feb, 2008, 12.04 AM IST
- Masterminded Matrix Lab’s rise to the top
The first-generation entrepreneur who masterminded Matrix Lab’s rise to the top is now focusing his efforts on promoting entrepreneurship.
21 Jul, 2007, 05.20 AM IST
- 'Deal is first step towards globalisation'
Matrix Labs’ CEO Rajiv Malik, who came on board July last year, appears to have his task cut out.
29 Aug, 2006, 03.05 AM IST
- Mylan to span out to Europe, Africa
The $1.2-bn US-based Mylan Labs may just have captured value across the chain with the Matrix deal.
29 Aug, 2006, 02.52 AM IST
- US pharma major Mylan buys Matrix Labs
The generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.
29 Aug, 2006, 01.58 AM IST